[wpml_language_switcher type="widget" flags=1 native=0 translated=0][/wpml_language_switcher] Proteção de Dados (LGPD) Resultados de Exames
Mario Penna

DOE AGORA
  • O que fazemos
    • Associações Voluntárias
    • Convênios
    • Comitê de Ética em Pesquisa
    • Direção
    • História
    • Missão, visão e valores
    • Qualidade e segurança
    • Residência e Especialização
    • Unidades
  • Notícias
  • Transparência
    • Compras e Licitações
      • Regulamento
      • Manual do Fornecedor
      • Cadastro SEI Externo
      • Aquisições
        • Hospital Luxemburgo
        • Hospital Regional de Teófilo Otoni
        • Hospital Raja
        • Hinova
    • Nossos Dados
      • Produção
      • Capacidade Instalada
      • Composição da Equipe Assistencial
    • Compliance
      • Programa de Ética e Compliance
      • Código de Conduta
      • Vídeos
    • Demonstrativos Financeiros
    • Editais e Documentos
    • Troco Solidário
    • Relatório de Igualdade Salarial
    • Relatórios e Planejamento
    • Revistas
    • Instrumentos de Repasse / Emendas
  • Fale Conosco
    • Trabalhe Conosco
    • Ouvidoria
    • Canal de Denúncias
  • Como Ajudar
  • —-
  • Hospital Luxemburgo
  • Portal do Câncer
  • Casa de Apoio Beatriz Ferraz
  • Instituto de Ensino, Pesquisa e Inovação
DOE AGORA

HOSPITAL LUXEMBURGO

NEXS I NÚCLEO DE EXCELÊNCIA EM SAÚDE

CASA DE APOIO BEATRIZ FERRAZ

NÚCLEO DE ENSINO, PESQUISA E INOVAÇÃO

Blog

5nov2021
Autor Carolina Farah Categorias care, General News, Health Ministry

Pastoral da Saúde distributes hygiene kits to IMP patients

Instituto Mário Penna has partners who enhance the work of our philanthropic and humanized work. The Pastoral da Saúde, led by President José Maurício Resende, is a great example of this. On July 16, during an action in partnership with the Humanization team, they gave a show of solidarity, distributing 100 hygiene kits to patients.

“Despite the pandemic and the care it requires, we don’t forget the patients here. We’ve been working for 35 years helping those in need and somehow we had to do something at that time. This delivery to do good is very rewarding”; emphasizes José Maurício.

Pastoral da Saúde is a great supporter of Instituto Mário Penna and is always present, offering assistance to those who need it when facing cancer, which is our specialty.

5nov2021
Autor Marketing Categorias Cancer Treatments, General News, Oncological Treatment

July Green: Instituto Mário Penna embraces head and neck cancer prevention campaign

Julho Verde arrived and with it a very important action embraced by Instituto Mário Penna: the campaign to prevent head and neck cancer. This is the name given to tumors that involve the airway-digestive tract region, such as tonsils, mouth, cheek, pharynx, gums, larynx, tongue and paranasal sinuses, and skin tumors in the face and neck region.

Focused on prevention and early diagnosis, the Institute launches its campaign with the slogan “Be aware of the signs”.

Throughout the month, shades of green and #stayatentoaosinais will take care of the Institution and our social networks.

According to the National Cancer Institute (Inca), head and neck cancer appears as the fourth highest incidence. In Brazil, more than 40 thousand people receive the diagnosis each year. In 2020, Instituto Mário Penna performed more than 6,000 consultations and 762 surgeries for these patients.

Be aware that symptoms are very common and can be confused. They are: hoarseness, pain or difficulty in swallowing for more than 15 days, mouth sores that do not heal or nodules (lumps) in the neck.

To prevent, maintain good hygiene and oral health, have a balanced diet rich in nutrients. Avoid prolonged sun exposure, excess alcohol and do not smoke.

Our team is made up of renowned surgeons in head and neck cancer, including doctors Alvimar Afonso, Lysio França, Lorenzo Testolin, Rafael Malheiros and Sérgio Negri.

“The surgeon is the most suitable professional for diagnosing and staging tumors that affect the region, in addition to performing surgical treatment modalities. The physician has the essential role of helping the patient to decide the best form of treatment for each individual case”; explains Lorenzo Testolin, surgeon and head and neck surgery residency coordinator at Instituto Mário Penna.

In addition, it is up to the physician to indicate the intervention of the Institute’s multidisciplinary team – formed by psychologists, physiotherapists, stomatologists, speech therapists and nutritionists – who will monitor each patient, according to their need.

Late diagnosis leaves sequelae in 60% of patients. Pay attention to your health. In case of discomfort or suspicion, seek medical attention. Diagnosed early, cancer is curable!

Click here and learn more about ways to prevent

Our service

Head and neck cancer patients at Instituto Mário Penna also have the support of our multidisciplinary team, made up of psychologists, physiotherapists, stomatologists, speech therapists and nutritionists. Learn a little more about the importance of each one.

Psychology: The diagnosis of cancer has a great physical and emotional impact. We are ready to help the patient with doubts and support decisions. The patient does not need to go through this difficult time alone.

Physiotherapy: Cancer of the larynx (vocal cords) brings radical changes in the way you breathe and swallow. Thus, associated respiratory diseases are common. We have an innovative project that provides outpatient physical therapy consultations for specific monitoring of patients with laryngeal cancer. This work is extremely important in the patient’s recovery and, thus, reducing hospitalizations. Care encompasses respiratory rehabilitation through specific exercises and guidance to improve the quality of life of the patient and family members involved in the treatment.

Stomatology: It is the specialty of dentistry that prevents, diagnoses and treats diseases that manifest in the mouth. It is of paramount importance in the care of patients, especially those undergoing chemotherapy and/or radiotherapy. These treatments can evolve with mucositis, compromising oral function (chewing, swallowing and pain when swallowing). Through stomatological treatment with medication and laser therapy, the effects of cancer treatment are mitigated, making it faster and more comfortable for the patient.

Speech-language pathology: The speech-language pathologist is essential in the assessment and treatment of patients affected by head and neck cancer. Such diseases can compromise voice, speech and nutrition, requiring adjustments and rehabilitation, regardless of the treatment modality. With speech therapy rehabilitation, patients can regain their communication, pleasure and security when eating.

Nutrition: The evaluation of a nutritionist is extremely important during the illness. Early nutritional support can reduce weight loss before, during and after completion of treatment, providing better results and better quality of life. About 80% of cancer patients are malnourished at diagnosis. This is due to an imbalance between intake and nutrient requirements, and is associated with increased morbidity and mortality – worse outcome.

Mário Penna Institute Choir

The discovery of laryngeal cancer could be the end of the voice for many people. For fourteen patients who lost their voice due to this type of cancer, it was the opportunity to learn to sing. They are part of the Mário Penna Institute’s Laryngectomized Choir and were reborn from singing.

The patients in the group underwent surgery for the total removal of the larynx – a procedure called “Laryngectomy” – completely losing their voice. However, with rehabilitation through esophageal voice acquisition or tracheoesophageal prosthesis implantation, they were able to resume communication.

The Mário Penna Institute, focused on excellence in care that includes diagnosis, treatment, rehabilitation and reintegration into society, is the only one in the capital that offers this service through the SUS.

These patients/singers have enchanted wherever they go and draw attention for the joy, pride and optimism with which they face life.

Coral has an important ally, Caixa Econômica Federal, responsible for 30% of its funding.

Electronic Larynx

The Mário Penna Institute reaches an important milestone in the history of SUS, being the first to receive Electronic Laryngs for patients undergoing surgery and who need rehabilitation for the use of their voice. The Mouth and Throat Cancer Association (ACBG) Brazil has been at the forefront of the fight to insert the device in the SUS table for years and approval was achieved in January 2021.

The electronic larynx, in addition to being a highly successful method in the rehabilitation process, provides the patient with conditions to resume their oral communication through the use of a device that produces a mechanical vibration and, when placed in contact with the skin in the region of neck, cheek or intraoral, produces a vocalization that is robotic and understandable, but in proportion to the tracheoesophageal prosthesis.

“It is a very important moment for Instituto Mário Penna. We have been fighting for years for this achievement by the SUS so that laryngectomized patients can speak again and express their feelings. Everyone will be covered, from the oldest to the newly operated. They will be trained in outpatient speech therapy, according to the rehabilitation program proposed and prepared by our team, which ranges from knowledge of the instrument’s potential to the acquisition of practice for its fluent use”; emphasizes Dr. Lorenzo Testolin.

5nov2021
Autor Marketing Categorias care, General News, Prevention Campaigns

August is the month to fight Lymphoma

August is Combat Lymphoma Month and many people know little or nothing about it. Therefore, the Mário Penna Institute supports the campaign and contributes to clarifying the disease in its media. Lymphomas are cancers that originate in the lymphatic system, a network of vessels and ganglia in our body responsible for storing the body’s defense cells.

Pedro Las Casas, a hematologist at the Instituto Mário Penna, explains that the disease arises when lymphocytes mutate and start to multiply in an uncontrolled manner, mainly inside the ganglia, causing them to increase in size. He points out that it is even possible that this proliferation occurs in other organs unrelated to the lymphatic system, such as the skin, lungs and nervous system.

“Lymphomas are divided into two types: Hodgkin’s and non-Hodgkin’s. Within these two groups it is possible to further divide them into several subtypes, each with completely different clinical characteristics and treatments. But only through the biopsy of the lesions is it possible to differentiate them”; account Dr. Pedro.

In general, the main symptoms of lymphomas are palpable and hardened nodes in the neck and armpits, which are usually painless and progressively growing. There are, however, other diseases that can lead to enlarged nodes, such as infections. Therefore, it is essential to seek a doctor for differential diagnosis if the nodes are progressively enlarged, are persistent or if they are accompanied by other symptoms such as persistent tiredness, daily fever, heavy sweating at night and weight loss.

The specialist also warns that for the diagnosis specific tests are needed, such as a biopsy of the ganglion or an organ suspected of being affected, blood tests and PET, a type of tomography that helps to identify the location of the lesions.

Dr. Pedro explains that the treatment of lymphomas varies according to the patient, the type of lymphoma and the degree of the disease. She points out that treatments are carried out through chemotherapy, immunotherapy and radiotherapy. “Unfortunately there is no form of prevention. When discovered at an early stage, the chances of cure or control are high. Therefore, it is important to always seek medical attention when symptoms are noticed”.

5nov2021
Autor Carolina Farah Categorias General News, Teaching and Research Center (NEP)

NEP: Would you like to volunteer in a clinical trial?

This question is usually asked by the clinical research team to patients at Instituto Mário Penna who can join clinical trials. But before hearing the answer, some explanations are essential.

A research volunteer, also known as a research participant, is a person who agrees to use a new drug that is in the testing phase and that may be beneficial for the treatment of cancer. The identification of potential volunteers is carried out by the team of oncologists who indicate those who can participate in the studies. For this invitation it is necessary to check three fundamental points:

1 – Does the test treatment provide more benefit than the standard treatment? In some situations, clinical studies offer medications that are not available in the SUS or in the health insurance, and that already show promising results compared to therapies used in routine, and that can increase lifespan or cause fewer side effects. In other situations, the patient has already gone through a long path of treatments and the therapy options have already been exhausted, leaving the oncologist to repeat a treatment that has already been done before. With clinical research it is possible to enable a new line of treatment.

2 – What happens when I participate in the clinical trial? The clinical study does not start before the patient is informed about the risks, benefits, follow-up tests, medications used, side effects, treatment time, consultations and all other information necessary to guarantee their right to make a decision. After clarification, a document called the Informed Consent Term (FICF) is signed by the patient and the physician responsible for the guidelines given. The term contains all the information discussed and the contacts of those responsible for the clinical protocol.

3 – Does the patient meet the study’s safety criteria? Before the clinical study arrives at Instituto Mário Penna, other analyzes are carried out regarding the drug, making it possible to know the main side effects it can cause, thus excluding patients who may have any risk factors for taking the medication. Several tests are performed between signing the consent form and before administering the first dose of medication, with the aim of getting to know the patient.

Cíntia Lima, Clinical Research Coordinator Nurse, emphasizes that a patient who is well informed about the possibilities of treatment in oncology will certainly have no difficulty in answering the question in the title of this text. She also reinforces that the mission of the clinical research team is to offer the best treatment to patients and ensure that their wishes are respected.

*Text written by Cíntia Lima, Enf. Clinical Research Coordinator

head and neck cancer
5nov2021
Autor Marketing Categorias General News, Teaching and Research Center (NEP)

NEP conducts research related to head and neck cancer

World Head and Neck Cancer Awareness Day is celebrated on July 27th. One of the main problems for the treatment of this type of cancer is the late diagnosis, which occurs in 60% of cases, leaving sequelae in the patient.
We all want to avoid cancer, but this is not always easy. On the other hand, in head and neck cancer we can prevent the disease simply by avoiding exposure to factors that are related to the onset of the disease. There are well-known risk factors that can be easily avoided. The first factor: overexposure to sunlight. The second factor: cigarettes and alcohol and the situation is worse when the person has the habit of consuming large amounts of alcohol and smokes a lot. The third factor: HPV virus, the same one that is related to the appearance of cervical cancer in women.

câncer de cabeça e pescoço

In addition to prevention, early diagnosis and rapid initiation of treatment are essential for the cure of head and neck cancer, reducing the impact on patients’ quality of life. The Teaching and Research Center (NEP), through a partnership between the Translational Research Laboratory and the Federal University of Minas Gerais (UFMG), develops the research project “Association between clinical and immunopathological aspects of orofacial pain and quality of life in patients with squamous cell carcinoma of the oral mucosa”. The research is carried out by the master’s student Francine Barros de Oliveira, from the Postgraduate Program in Pathology at UFMG, under the guidance of Profa. Dr. Camila Megale Almeida-Leite (Dept of Morphology/Institute of Biological Sciences/UFMG) and co-supervision of Dr. Patricia Rocha Martins.

Dr. Paulo Guilherme de Oliveira Salles, Dr. Paulo Guilherme de Oliveira Salles, also participate in the research as members of the Mário Penna Institute (IMP) team. Juliana Maria Braga Sclauser and Dr. Letícia Braga, in addition to the medical team at the head and neck clinic. The project aims to evaluate in oral cancer patients seeking treatment at IMP, potential relationships between cancer characteristics, orofacial pain presented by the patient and quality of life.

According to Dr. Camila Megale, this research is the starting point for more detailed studies on the type of orofacial pain that patients with head and neck cancer have and how the type of cancer can interfere with pain as a symptom. “In the future, the results obtained will allow for an early treatment of the patient’s pain in a more specific way, based on information obtained from the biopsy and the initial consultations, which will make orofacial pain relief more effective.”

 

 

 

Página anterior 1 … 128 129 130 131 132 … 218 Próxima página

Categorias

  • 50 anos Instituto Mário Penna
  • 50 years IMP
  • Agenda Mário Penna
  • Assistencial
  • BH
  • BH
  • Blog Portal do Câncer
  • Campanhas de Prevenção
  • Cancer Treatments
  • Casa de Apoio Beatriz Ferraz
  • Cofinho do Bem
  • colaboradores
  • Correios
  • Corrida da Esperança
  • Covid
  • Cuidados Paliativos
  • Curso de Gestão
  • Cursos
  • Dezembro Laranja
  • Dia Internacional da Mulher
  • Diretoria
  • Droga Clara
  • Ensino, Pesquisa e Inovação
  • Entrevista
  • Espaço Mulher
  • Estrelas Mário Penna
  • Fundo do Idoso
  • General News
  • Heróis Mário Penna
  • Histórias de pacientes
  • Histórias de pacientes,Hospital Luxemburgo,Notícias Gerais
  • Histórias de pacientes,Hospital Luxemburgo,Notícias Gerais,Oncologia
  • Hospital Luxemburgo
  • Hospital Luxemburgo,Notícias Gerais,Oncologia
  • Hospital Luxemburgo,Oncologia
  • Hospital Mário Penna
  • Hospital Regional de Teófilo Otoni
  • Humanização
  • Imposto de Renda
  • Infofarma
  • Instituto Mário Penna
  • Janeiro Branco
  • Julho Verde
  • Linfomas
  • Lista do Bem
  • Lojas Redes
  • Luxembourg Hospital
  • Março Lilás
  • Mario Penna de Todos
  • Maternidade Real
  • Minas na Mesa
  • Momento do Bem
  • Musica no Hospital
  • Não categorizado
  • NEXS
  • Notícias Gerais
  • Notícias Gerais, Oncologia
  • Nova Marca
  • Novembro Azul
  • Novo Hospital Luxemburgo
  • Núcleo de Ensino e Pesquisa (NEP
  • Núcleo de Especialidades Oncológicas (NEO
  • Outubro Rosa
  • Parceiros
  • Partners
  • Pastoral da Saúde
  • Pink October
  • Projeto Reintegrar
  • Reunião Multidisciplinar
  • Teaching and Research Center (NEP
  • Todos Juntos Contra o Câncer
  • Tratamento Oncológico
  • Tratamentos Contra o Câncer
  • Verdemar

Assine nossa Newsletter

Fique por dentro de tudo que acontece no Instituto Mário Penna

0800 039 1441

DOAÇÕES POR TELEFONE

SALA DE IMPRENSA

ACESSE POR AQUI

Conecte-se com o Instituto Mario Penna

  • facebook
  • instagram
  • youtube
  • linkedin
Copyright © 2020 Mario Penna. Todos os direitos reservados.CNPJ: 17.513.235/0001-80
Olá, como podemos ajudar?

Damos valor à sua privacidade

Nós e os nossos parceiros armazenamos ou acedemos a informações dos dispositivos, tais como cookies, e processamos dados pessoais, tais como identificadores exclusivos e informações padrão enviadas pelos dispositivos, para as finalidades descritas abaixo. Poderá clicar para consentir o processamento por nossa parte e pela parte dos nossos parceiros para tais finalidades. Em alternativa, poderá clicar para recusar o consentimento, ou aceder a informações mais pormenorizadas e alterar as suas preferências antes de dar consentimento. As suas preferências serão aplicadas apenas a este website.

Cookies estritamente necessários

Estes cookies são necessários para que o website funcione e não podem ser desligados nos nossos sistemas. Normalmente, eles só são configurados em resposta a ações levadas a cabo por si e que correspondem a uma solicitação de serviços, tais como definir as suas preferências de privacidade, iniciar sessão ou preencher formulários. Pode configurar o seu navegador para bloquear ou alertá-lo(a) sobre esses cookies, mas algumas partes do website não funcionarão. Estes cookies não armazenam qualquer informação pessoal identificável.

Cookies de desempenho

Estes cookies permitem-nos contar visitas e fontes de tráfego, para que possamos medir e melhorar o desempenho do nosso website. Eles ajudam-nos a saber quais são as páginas mais e menos populares e a ver como os visitantes se movimentam pelo website. Todas as informações recolhidas por estes cookies são agregadas e, por conseguinte, anónimas. Se não permitir estes cookies, não saberemos quando visitou o nosso site.

Cookies de funcionalidade

Estes cookies permitem que o site forneça uma funcionalidade e personalização melhoradas. Podem ser estabelecidos por nós ou por fornecedores externos cujos serviços adicionámos às nossas páginas. Se não permitir estes cookies algumas destas funcionalidades, ou mesmo todas, podem não atuar corretamente.

Cookies de publicidade

Estes cookies podem ser estabelecidos através do nosso site pelos nossos parceiros de publicidade. Podem ser usados por essas empresas para construir um perfil sobre os seus interesses e mostrar-lhe anúncios relevantes em outros websites. Eles não armazenam diretamente informações pessoais, mas são baseados na identificação exclusiva do seu navegador e dispositivo de internet. Se não permitir estes cookies, terá menos publicidade direcionada.

Visite as nossas páginas de Políticas de privacidade e Termos e condições.

Importante: Este site faz uso de cookies que podem conter informações de rastreamento sobre os visitantes.

[cd_calculate_form]

[cd_calculate_form]